NCT03791710

Brief Summary

the study evaluates the role of autologous fat grafting and the usage of nanofat in the treatment of the acute burn injuries in different genders and its influences on the healing time and hospital stay, pain control, the need and take of a split thickness skin graft and its size, and the end resulting early scarring, in comparison with control group that were treated with traditional methods, so as to find out new method of treating burn injuries and decreasing its morbidity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Mar 2019

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 27, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 3, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

March 14, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2020

Completed
Last Updated

July 10, 2020

Status Verified

July 1, 2020

Enrollment Period

11 months

First QC Date

December 27, 2018

Last Update Submit

July 9, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • wound healing time

    the effect of the fat grafting on the wound healing time

    one to three weeks

Secondary Outcomes (1)

  • effect on pain perception, subjective assessment scale

    immediate post-operative and up to three weeks

Study Arms (2)

control group

PLACEBO COMPARATOR

this group of patients are treated with the regular conventional methods like application of topical agents e.g silver sulphadiazine

Drug: Topical CreamProcedure: split thickness skin grafting

fat grafting group

ACTIVE COMPARATOR

this group of patients will have the autologous fat grafting for their burn wounds

Procedure: autologous fat graftingProcedure: split thickness skin grafting

Interventions

regular liposuction procedure at which sufficient amount of fat is extracted from the patient and then the fat is processed then grafted underneath the burn wound

Also known as: liposuction and lipofilling
fat grafting group

serial dressing with topical agents e.g Silver Sulphadiazine

Also known as: dressing
control group

depridment and split thickness skin grafting

Also known as: skin grafting
control groupfat grafting group

Eligibility Criteria

Age13 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • both males and females within the age frame are candidates.
  • previously healthy individuals with no co-morbid conditions e.g cardiac, hepatic, diabetic, vascular or renal disease.
  • with TBSA of 10 to 30% affected and of deep dermal to full thickness wound depth, at any part of the body except the genitalia, perineum or the perianal region or those with inhalational injury.

You may not qualify if:

  • other patients aged younger or older than the specified age group.
  • patients with co-morbid conditions.
  • patients with smaller or larger BSA than the specified BSA.
  • burns involving the genitalia, perineum or the perianal region and patients with inhalational injury.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Abouqir General Hospital

Alexandria, 21527, Egypt

Location

Related Publications (1)

  • Abouzaid AM, El Mokadem ME, Aboubakr AK, Kassem MA, Al Shora AK, Solaiman A. Effect of autologous fat transfer in acute burn wound management: A randomized controlled study. Burns. 2022 Sep;48(6):1368-1385. doi: 10.1016/j.burns.2021.10.011. Epub 2021 Nov 1.

MeSH Terms

Conditions

Burns

Interventions

LipectomyFloderm topical creamBandagesSkin Transplantation

Condition Hierarchy (Ancestors)

Wounds and Injuries

Intervention Hierarchy (Ancestors)

Cosmetic TechniquesTherapeuticsBariatric SurgeryBariatricsObesity ManagementSurgical Procedures, OperativePlastic Surgery ProceduresEquipment and SuppliesTissue TransplantationCell- and Tissue-Based TherapyBiological TherapyDermatologic Surgical ProceduresTransplantation

Study Officials

  • Ahmed M Abouzaid, MSc

    Abouqir GH

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: two groups one will have the fat grafting and the other will be the control group treated with the conventional methods
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
specialist plastic, reconstructive surgery and burn therapy

Study Record Dates

First Submitted

December 27, 2018

First Posted

January 3, 2019

Study Start

March 14, 2019

Primary Completion

January 31, 2020

Study Completion

January 31, 2020

Last Updated

July 10, 2020

Record last verified: 2020-07

Locations